Literature DB >> 11967232

Biological and genetic properties of the p53 null preneoplastic mammary epithelium.

Daniel Medina1, Frances S Kittrell, Anne Shepard, L Clifton Stephens, Cheng Jiang, Junxuan Lu, D Craig Allred, Maureen McCarthy, Robert L Ullrich.   

Abstract

The absence of the tumor suppressor gene p53 confers an increased tumorigenic risk for mammary epithelial cells. In this report, we describe the biological and genetic properties of the p53 null preneoplastic mouse mammary epithelium in a p53 wild-type environment. Mammary epithelium from p53 null mice was transplanted serially into the cleared mammary fat pads of p53 wild-type BALB/c female to develop stable outgrowth lines. The outgrowth lines were transplanted for 10 generations. The outgrowths were ductal in morphology and progressed through ductal hyperplasia and ductal carcinoma in situ before invasive cancer. The preneoplastic outgrowth lines were immortal and exhibited activated telomerase activity. They are estrogen and progesterone receptor-positive, and aneuploid, and had various levels of tumorigenic potential. The biological and genetic properties of these lines are distinct from those found in most hyperplastic alveolar outgrowth lines, the form of mammary preneoplasia occurring in most traditional models of murine mammary tumorigenesis. These results indicate that the preneoplastic cell populations found in this genetically engineered model are similar in biological properties to a subset of precurser lesions found in human breast cancer and provide a unique model to identify secondary events critical for tumorigenicity and invasiveness.

Entities:  

Keywords:  NASA Discipline Radiation Health; Non-NASA Center

Mesh:

Substances:

Year:  2002        PMID: 11967232     DOI: 10.1096/fj.01-0885fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  54 in total

Review 1.  Murine mammary epithelial stem cells: discovery, function, and current status.

Authors:  Jane E Visvader; Gilbert H Smith
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

Review 2.  Interrogating mouse mammary cancer models: insights from gene expression profiling.

Authors:  Antonio A Fargiano; Kartiki V Desai; Jeffrey E Green
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

Review 3.  Stromal mediation of radiation carcinogenesis.

Authors:  Mary Helen Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-12-23       Impact factor: 2.673

4.  Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.

Authors:  Daniel Medina; Frances Kittrell; Jamal Hill; Yun Zhang; Susan G Hilsenbeck; Reid Bissonette; Powel H Brown
Journal:  Cancer Prev Res (Phila)       Date:  2009-01-27

5.  Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model.

Authors:  Martín C Abba; Yuhui Hu; Carla C Levy; Sally Gaddis; Frances S Kittrell; Jamal Hill; Reid P Bissonnette; Powel H Brown; Daniel Medina; C Marcelo Aldaz
Journal:  Cancer Prev Res (Phila)       Date:  2009-01-27

6.  Altered mammary gland development in the p53+/m mouse, a model of accelerated aging.

Authors:  Catherine E Gatza; Melissa Dumble; Frances Kittrell; David G Edwards; Robert K Dearth; Adrian V Lee; Jianming Xu; Daniel Medina; Lawrence A Donehower
Journal:  Dev Biol       Date:  2007-10-12       Impact factor: 3.582

Review 7.  New biological insights on the link between radiation exposure and breast cancer risk.

Authors:  Mary Helen Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-01-17       Impact factor: 2.673

Review 8.  Of mice and Myc: c-Myc and mammary tumorigenesis.

Authors:  M Hunter Jamerson; Michael D Johnson; Robert B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

9.  Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice.

Authors:  Tracy E Strecker; Qiang Shen; Yun Zhang; Jamal L Hill; Yuxin Li; Chunyu Wang; Hee-Tae Kim; Tona M Gilmer; Krystal R Sexton; Susan G Hilsenbeck; C Kent Osborne; Powel H Brown
Journal:  J Natl Cancer Inst       Date:  2009-01-13       Impact factor: 13.506

Review 10.  Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens.

Authors:  Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-29       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.